A detailed history of Drw Securities, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Drw Securities, LLC holds 6,226 shares of ABT stock, worth $699,802. This represents 0.03% of its overall portfolio holdings.

Number of Shares
6,226
Previous 10,505 40.73%
Holding current value
$699,802
Previous $1.19 Million 45.85%
% of portfolio
0.03%
Previous 0.03%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

SELL
$100.73 - $112.44 $431,023 - $481,130
-4,279 Reduced 40.73%
6,226 $646,000
Q1 2024

May 14, 2024

BUY
$109.52 - $120.96 $936,176 - $1.03 Million
8,548 Added 436.79%
10,505 $1.19 Million
Q4 2023

Feb 16, 2024

SELL
$90.19 - $110.4 $350,388 - $428,904
-3,885 Reduced 66.5%
1,957 $215,000
Q3 2023

Nov 13, 2023

BUY
$95.53 - $114.62 $104,318 - $125,165
1,092 Added 22.99%
5,842 $566,000
Q2 2023

Aug 14, 2023

SELL
$100.78 - $112.29 $371,273 - $413,676
-3,684 Reduced 43.68%
4,750 $518,000
Q1 2023

May 15, 2023

BUY
$96.86 - $114.01 $816,917 - $961,560
8,434 New
8,434 $854,000
Q2 2022

Aug 12, 2022

BUY
$102.07 - $123.37 $77,471 - $93,637
759 Added 9.21%
8,997 $978,000
Q1 2022

May 12, 2022

BUY
$114.02 - $139.04 $384,133 - $468,425
3,369 Added 69.19%
8,238 $975,000
Q4 2021

Feb 14, 2022

SELL
$115.53 - $141.46 $151,806 - $185,878
-1,314 Reduced 21.25%
4,869 $685,000
Q2 2021

Aug 12, 2021

BUY
$105.79 - $124.53 $654,099 - $769,968
6,183 New
6,183 $717,000
Q3 2019

Nov 14, 2019

SELL
$81.84 - $88.74 $1.26 Million - $1.37 Million
-15,456 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$72.88 - $85.0 $1.13 Million - $1.31 Million
15,456 New
15,456 $1.3 Million
Q1 2018

May 14, 2018

SELL
$56.27 - $63.62 $1.37 Million - $1.55 Million
-24,408 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$53.68 - $57.47 $1.31 Million - $1.4 Million
24,408
24,408 $1.39 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $197B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Drw Securities, LLC Portfolio

Follow Drw Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Drw Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Drw Securities, LLC with notifications on news.